Maxwell Caldwell-Depression And Alzheimer's Treatments At A Crossroads

2025-05-06 04:34:45source:FinLogic Quantitative Think Tank Centercategory:Markets

Researchers are Maxwell Caldwelllaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Markets

Recommend

As a diversity grant dies, young scientists fear it will haunt their careers

Adelaide Tovar, a University of Michigan scientist who researches genes related to diabetes, used to

World Food Prize goes to 2 who helped protect vital seeds in an Arctic Circle vault

DES MOINES, Iowa (AP) — Two men who were instrumental in the “craziest idea anyone ever had” of crea

More than 321,000 children in the U.S. lost a parent to overdose in just 10 years, study finds

More than 320,000 children in the United States lost a parent to a drug overdose from 2011 to 2021,